INHIBITION OF HUMAN-TUMOR CLONOGENICITY BY CHLORAMBUCIL AND ITS METABOLITES

被引：10

作者：

GOODMAN, GE

MCLEAN, A

ALBERTS, DS

CHANG, SY

机构：

[1] UNIV ARIZONA,DEPT MED,HAMATOL ONKOL SECT,TUCSON,AZ 85724

[2] UNIV ARIZONA,DEPT PHARMACOL,TUCSON,AZ 85724

[3] UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724

[4] SWEDISH HOSP,INST TUMOR,SEATTLE,WA 98104

[5] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104

[6] UNIV TEXAS,DEPT PHARM,AUSTIN,TX 78712

[7] MCNEIL LABS INC,DEPT ANALYT CHEM,FT WASHINGTON,PA 19034

来源：

BRITISH JOURNAL OF CANCER | 1982年 / 45卷 / 04期

关键词：

D O I：

10.1038/bjc.1982.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：621 / 623

页数：3

共 6 条

[1] PHARMACOKINETICS AND METABOLISM OF CHLORAMBUCIL IN MAN - PRELIMINARY-REPORT [J].

ALBERTS, DS ;

CHANG, SY ;

CHEN, HSG ;

LARCOM, BJ ;

JONES, SE .

CANCER TREATMENT REVIEWS, 1979, 6 :9-17

[2]

GOODMAN LS, 1975, PHARMACOL BASIS THER, P1254

[3] ESTABLISHMENT OF A CELL LINE OF HUMAN ENDOMETRIAL ADENOCARCINOMA IN-VITRO [J].

KURAMOTO, H ;

TAMURA, S ;

NOTAKE, Y .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 114 (08) :1012-1019

[4] THE METABOLISM OF CHLORAMBUCIL [J].

MCLEAN, A ;

NEWELL, D ;

BAKER, G ;

CONNORS, T .

BIOCHEMICAL PHARMACOLOGY, 1980, 29 (14) :2039-2047

[5]

MCLEAN A, 1979, CANCER TREAT REV S3, V6

[6] QUANTITATION OF DIFFERENTIAL SENSITIVITY OF HUMAN-TUMOR STEM-CELLS TO ANTI-CANCER DRUGS [J].

SALMON, SE ;

HAMBURGER, AW ;

SOEHNLEN, B ;

DURIE, BGM ;

ALBERTS, DS ;

MOON, TE .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (24) :1321-1327

← 1 →